Key result
The AA genotype of the IL-18 rs1946518 variant was associated with a decreased risk of systemic lupus erythematosus compared to the CC genotype.
Why the study?
Are IL-18 functional variants rs1946518 and rs187238 associated with the risk of developing systemic lupus erythematosus and its clinical severity?
Case-Control (n=251)
Are IL-18 functional variants rs1946518 and rs187238 associated with the risk of developing systemic lupus erythematosus and its clinical severity?
Answers are grounded in this paper and cite their sources.
Functional variants rs1946518 and rs187238 in the IL-18 promoter are associated with a reduced risk of systemic lupus erythematosus and milder disease severity.
Objective Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a complex etiology. Interleukin-18 (IL-18) possesses pro-inflammatory properties and plays a central role in the development of SLE. In this study, we assessed the association between two functional variants that affect the expression of IL-18 , namely −607C > A (rs1946518) and −137G > C (rs187238), and the risk of SLE development. Methods As a case-control study, 251 peripheral blood samples were collected from 121 SLE patients and 130 healthy participants. Genotyping of these polymorphisms was performed using the high-resolution melting (HRM) method, which employs real-time polymerase chain reaction. Results Our findings revealed a significant association between the AA genotype and A allele in rs1946518, showing a decreased risk of SLE (AA vs CC; OR: 0.386; 95% CI [0.174–0.828], A vs C; OR: 0.548; 95% CI [0.369–0.809]). Analogously, the CC genotype and C allele in rs187238 exhibited a similar trend (CC vs GG; OR: 0.240; 95% CI [0.055–0.803], C vs G; OR: 0.604; 95% CI [0.390–0.928]), indicating a reduced risk of SLE Moreover, SLE subjects with the protective allele in rs1946518 (AA + AC) demonstrated significantly lower levels of CRP, and Anti-dsDNA, suggesting lower disease activity. These patients also had a later age of onset, and a lower incidence of renal involvement and creatinine levels, indicating milder disease severity ( p < .05 ). Conclusion The study indicates a significant relationship between the rs1946518 and rs187238 variants in IL-18 and a reduced risk of SLE. Furthermore, rs1946518 was found to be associated with certain clinical features related to disease activity and severity.
No takes yet. Share an insight, caveat, or question.
Mohammadi et al. (2025) conducted a case-control in Systemic lupus erythematosus (SLE) (n=251). IL-18 functional variants rs1946518 and rs187238 vs. Reference genotypes (CC for rs1946518, GG for rs187238) was evaluated on Risk of SLE development (AA vs CC genotype in rs1946518) (OR 0.386, 95% CI 0.174-0.828). The AA genotype of the IL-18 rs1946518 variant was associated with a decreased risk of systemic lupus erythematosus compared to the CC genotype.
Synapse has enriched 10 related papers. Consider them for comparative context: